• The worldwide market for prescrip-
tion dermatological products reached
$23.4 billion in 2016, growing at a rate
of 9.3% from 2014 to 2016, according to
Kalorama Information. The New York City-based market research firm said that the
antiaging and photodamage, psoriasis and
skin cancer treatments dermatology drug
sectors showed the most dramatic gains.
Sales of prescription acne and rosacea,
dermatitis and seborrhea, fungal infection,
hair loss/removal, hyperpigmentation/me-lasma and miscellaneous skin disorders
reflected a slower growth rate during this
period because many of the drugs are older
and have lost patent protection.
The findings come from the tenth
edition of the company’s Prescription
Dermatological Drugs report.
“This is an exciting time in dermatol-
ogy as there continues to be a shift in the
understanding of the pathophysiology
of many skin diseases,” said Mary Ann
Crandall. “And there’s new biologics and
their uses in dermatology.”
Crandall also said there are new
trends such as a movement toward dis-
pensing prescription dermatology agents
in the office.
Another interesting area is the growth
in the demand for platelet rich plasma.
When PRP is injected into the damaged
area, it stimulates the tissue, causing
mild inflammation that triggers a healing
cascade. This area of medicine has blos-
somed due to an increase in skin cancer
incidence, new exciting biologics for pso-
riasis, increased demand by baby boom-
ers (both men and women) for antiaging
products, consolidation within the indus-
try and strong late stage pipeline entities,
The worldwide market for prescription dermatological drugs encompasses
a wide variety of products that treat disorders of the skin as well as the effects
of aging. The field of dermatology is currently experiencing a busy and interesting period and, as a result, the range of
therapeutic options available to physicians has expanded.
According to Kalorama, while there
are a number of companies participating
in the worldwide market for prescription
dermatological drugs—ranging from large
international pharmaceutical companies,
small niche pharmaceutical companies
to generic companies both large and
small—there is also competitive pressure
from over-the-counter (O TC) participants.
However, even with the availability of
OTC products, manufacturers of prescription products continue to do well in terms
of revenues. Demand for products in the
prescription dermatological market will
likely remain high due to the aging population and the quest for lifestyle treatments to meet the needs of aging baby
boomers. Competitors are increasingly offering products that meet this need, which
is an entirely different concept than other
products that the companies may offer.
Consumer Wipes Market
To Hit $1.9 Billion in 2021
• Consumer wipes accounted for 56%
of overall wipes sales in 2016, and demand
for consumer wipes is expected to increase
2.5% a year to $1.9 billion in 2021, according to a report from The Freedonia Group.
More than 80% of consumer wipes
sales in 2016 were for personal care wipes,
with baby wipes accounting for the majority of personal care wipes sales. However,
given the maturity of the baby wipes market, the fastest growth among consumer
wipes will be tied to sales of household
care and other consumer wipes.
These and other trends are presented
in Wipes Market in the US, 8th Edition, a
new study from The Freedonia Group, a
Cleveland-based industry research firm.
In household care wipes, 32% of sales are
tied to dry wipes, primarily due to the floor
care segment. In this application, wipes are
often used to lift away light soils such as dust
and small amounts of dirt without the help
of a solvent or surfactant. This is often due
to an electrostatic charge that can attract and
hold dust and other small particles.
There are significant differences in the
market shares of the several segments of
the personal care wipes market, depending
on whether share is measured in value or
in volume terms. By volume, baby wipes
accounted for about 82% of personal care
wipes in 2016, while in value terms they ac-
counted for only 67% of the segment.
ANTI-AGING, SUN DAMAGE PROPEL
PRESCRIPTION DERM SECTOR
Happi’s sixth Anti-Aging
Conference & Tabletop Exhibition
will be held Nov. 29-30, 2017
in New Brunswick, NJ.
More info: conference.happi.com
Photodamage is fueling prescription skin care.
Household wipes will drive growth in the category.